| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| ACEBILUSTAT | Small molecule | lymphedema | Leukotriene A4 hydrolase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ACEBILUSTAT | Small molecule | COVID-19 | Leukotriene A4 hydrolase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ACEBILUSTAT | Small molecule | cystic fibrosis | Leukotriene A4 hydrolase inhibitor | 1.0 | Completed | ClinicalTrials |
| ACEBILUSTAT | Small molecule | cystic fibrosis | Leukotriene A4 hydrolase inhibitor | 2.0 | Completed | ClinicalTrials |
| ACEBILUSTAT | Small molecule | acne | Leukotriene A4 hydrolase inhibitor | 2.0 | Completed | ClinicalTrials |